ZA200600682B - (+)-2[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof - Google Patents

(+)-2[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof

Info

Publication number
ZA200600682B
ZA200600682B ZA200600682A ZA200600682A ZA200600682B ZA 200600682 B ZA200600682 B ZA 200600682B ZA 200600682 A ZA200600682 A ZA 200600682A ZA 200600682 A ZA200600682 A ZA 200600682A ZA 200600682 B ZA200600682 B ZA 200600682B
Authority
ZA
South Africa
Prior art keywords
acetylaminoisoindoline
methylsulfonylethyl
dione
methoxyphenyl
ethoxy
Prior art date
Application number
ZA200600682A
Inventor
Peter H Schafer
George W Muller
Man Hon-Wah
Ge Chuansheng
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of ZA200600682B publication Critical patent/ZA200600682B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200600682A 2002-03-20 2003-03-20 (+)-2[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof ZA200600682B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36651502P 2002-03-20 2002-03-20

Publications (1)

Publication Number Publication Date
ZA200600682B true ZA200600682B (en) 2007-03-28

Family

ID=38074916

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200600682A ZA200600682B (en) 2002-03-20 2003-03-20 (+)-2[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof

Country Status (2)

Country Link
CN (1) CN1965823B (en)
ZA (1) ZA200600682B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102898349A (en) * 2008-03-27 2013-01-30 细胞基因公司 Solid containing compound, a composition containing the solid and use of the solid
CN104910062A (en) * 2015-05-16 2015-09-16 南京海纳医药科技有限公司 Apremilast refining method
CN105085373B (en) * 2015-09-01 2018-02-09 苏州大学 A kind of purification process to Apremilast product
CN111821297A (en) * 2019-04-16 2020-10-27 天津合美医药科技有限公司 Use of isoindoline derivatives for the treatment of immunoglobulin E (IgE) -mediated diseases
CN115068491A (en) * 2021-03-15 2022-09-20 中国医学科学院药物研究所 Medical application of andrographolide as LTB4 receptor inhibitor
CN114790164B (en) 2021-08-13 2022-12-27 苏州璞正医药有限公司 Substituted isoindoline-1,3-diketone PDE4 inhibitor and pharmaceutical application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels

Also Published As

Publication number Publication date
CN1965823A (en) 2007-05-23
CN1965823B (en) 2010-05-12

Similar Documents

Publication Publication Date Title
CY2019032I1 (en) (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULPHONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USE AND COMPOSITIONS THEREOF
AU2003222034A1 (en) (-)-2-(1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl)-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
AU2003298514A1 (en) Methods and compositions using cholinesterase inhibitors
IL167832A (en) Sesquiterpene synthases and methods of use
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003274652A1 (en) Compounds, compositions and methods for modulating fat metabolism
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003241307A1 (en) High throughput microbalance and methods of using same
AU2002320057A1 (en) Herbal composition for improving oral hygiene, and methods of using same
AU2003253664A1 (en) Compositions and methods for reducing lung volume
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003239614A1 (en) Cardiolipin compositions, methods of preparation and use
EP1539218A4 (en) Compositions and methods for modulating lymphocyte activity
AU2003298786A1 (en) Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
AU2003270015A1 (en) Compounds, compositions, and methods
AU2003236527A8 (en) Compounds, compositions, and methods
EP1572944A4 (en) Methods and compositions for modulating xbp-1 activity
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2003288221A1 (en) Skin lightening derivatives of di-thiane resorcinol, compositions and methods
PL374646A1 (en) Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
AU2003206882A1 (en) Analysis of vital substances
AU2003247351A1 (en) Anti-acne compositions and methods of use
EP1624880A4 (en) Annatto extract compositions, including geranyl geraniols and methods of use
ZA200600682B (en) (+)-2[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof
AU2003277079A8 (en) Compounds, compositions, and methods